Michigan Senate Candidate Mike Rogers Faces Scrutiny Over Opioid Record
Mike Rogers, a Republican candidate vying for a U.S. Senate seat in Michigan, has come under fire for allegedly distorting his track record in combating the opioid crisis. In a recent editorial for Deadline Detroit, Rogers outlined his past efforts, but critics argue that his claims do not align with his legislative history.
During his tenure in Congress from 2001 to 2015, Rogers was a proponent of the National Pain Care Policy Act. However, this legislation has been criticized for potentially encouraging the use of opioids such as OxyContin for chronic pain management. The act did not incorporate penalties for physicians who overprescribed, nor did it impose prescribing limits or expand the scope of law enforcement regarding opioid regulation.
Rogers defended his actions by stating, “In Congress, I voted to allow Americans who are suffering from debilitating pain to have access to the treatment they need to live comfortably.” He emphasized that the act included measures to curb overprescription and addiction, a claim disputed by evidence showing the lack of such safeguards.
Back in 2003, Rogers publicly endorsed the National Pain Care Policy Act alongside the American Pain Society, a group that advocated for pharmaceutical treatments for chronic pain. This organization disbanded in 2019 amid accusations of collaboration with pharmaceutical companies to promote opioid use, as reported by The Guardian.
Financial ties to the pharmaceutical sector have also been a point of contention for Rogers. He has reportedly received over $1 million in contributions from pharmaceutical and healthcare-related entities since 1999. This financial support has fueled criticism regarding his stance and actions on drug pricing and regulation matters.
According to data from the Michigan Department of Health and Human Services, there is a strong correlation between opioid prescription rates and overdose incidents in Michigan, particularly during 2001-2010. Following the FDA’s 2010 measures to tighten opioid prescription guidelines and reformulate OxyContin, a surge in heroin and fentanyl overdoses was observed.
Despite these controversies, Rogers is anticipated to secure a win in the upcoming August 4 Republican primary in Michigan. His previous attempt for a U.S. Senate seat in 2024 was unsuccessful. On the Democratic side, several contenders including Rep. Haley Stevens, state Sen. Mallory McMorrow, and physician Abdul El-Sayed are competing for the chance to face Rogers.
The original report on Rogers’ campaign and his opioid policy record can be found on American Journal News.
—
Read More Kitchen Table News
